CNS Company Showcase Pain Management


Novai is a UK-based early stage company focused on developing ophthalmic solutions. The company, using DARC technology (AI biomarker) is able to identify cellular level disease activity in degenerative neurological diseases. Novai has phase II data primarily in Glaucoma, however several other indications may follow AMD, multiple sclerosis, Alzheimer’s and Parkinson’s disease.

Novai是一家总部位于英国的早期临床公司,致力于开发眼科解决方案。该公司使用DARC技术(AI生物标记物)能够识别变性神经疾病中的细胞水平疾病活性。 Novai主要在青光眼中获得II期数据,但是其他一些适应症可能是AMD,多发性硬化症,阿尔茨海默氏病和帕金森氏病。